If you’re starting in the stock market and are seeking some long-term investments, keep reading. There are many stocks to invest in and different strategies to do so. The trick is to find a stock that has the potential to grow manifold over the coming years. Beyond buying a stock because it’s cheap or you like its business, certain qualities set great stocks apart from mediocre ones: Marketable: Great stocks beat the market, meet rising demand and generate lots of free cash flow with little debt.
Amazon stock forecast today is $3,680, Tesla stock forecast today is $976.82, and PayPal stock forecast today is $124.27. Its executives also manage a great company well, has a solid balance sheet, and return value to shareholders through dividend payments or share repurchases. So let’s look at the best stocks to buy now in 2022, which can give you high returns over the next five years if you invest wisely now.
Gilead Sciences(NASDAQ:GILD)
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes medicines in areas of unmet medical need. The company’s focus areas include virology, hematology, inflammation, oncology, and cardiovascular and metabolic diseases. Gilead’s core business segments include Research and Development or R&D, which focuses on discovering, acquiring, and developing novel human therapeutics; Commercial, which markets Gilead’s products either through its sales force or by collaborating with third parties; and Government and Corporate, which includes Gilead’s government affairs, medical philanthropy, and corporate operations functions. Gilead’s research and development and commercialization efforts are focused on five therapeutic areas: hepatitis B virus, or HBV, and hepatitis C virus, or HCV, cancers, HIV, and cardiovascular diseases. Gilead’s operating segments include the Commercial segment, the R&D segment, and the Government and Corporate segment. The Commercial part consists of Gilead’s sales and marketing activities and research and development related to Gilead’s products that the R&D segment does not cover. The R&D segment consists of research and development activities for Gilead’s research and development pipeline and product candidates covered by the Commercial segment. The Government and Corporate part include Gilead’s government affairs, medical philanthropy, and corporate operations. Gilead has a market cap of $54.1 billion. The company has a P/E ratio of 11.7, a P/S ratio of 2.34, and a P/B ratio of 3.2. Gilead Sciences has a 5-year average ROE of 30%, a 5-year average ROC of 25%, and a 5-year average gross margin of 81%.
Varonis Systems Inc (NASDAQ: VRNS)
Varonis Systems is a leading software provider for unstructured data protection and governance. The company’s data governance, analytics, and data security products are built from one platform, the Varonis Data Framework™, a term coined by the company. Varonis Data Framework is a technology platform that digitizes, organizes, and analyzes data from any structured or unstructured source. The company’s platform helps organizations protect data from cyber threats, reduce risk and regulatory penalties, detect insider threats, and increase operational efficiency. Varonis Systems has customers in more than 80 countries and has offices in the United States, Europe, and the Asia Pacific. According to Markets and Markets, the data governance, analytics, and security market is expected to grow to $48.8 billion by 2022. Varonis has a market cap of $2.1 billion. The company has a P/E ratio of 45.5, a P/S ratio of 7.1, and a P/B ratio of 2.3. Varonis Systems has a 5-year average ROE of 23%, a 5-year average ROC of 32%, and a 5-year average gross margin of 82%.
Workday, Inc.(NASDAQ: WDAY)
Workday is an enterprise cloud company offering people-focused solutions that help organizations transform the way they work. The company’s products include a core HR solution for core HR, payroll, and benefits administration; Workday Talent, a cloud-based solution that manages the entire employee lifecycle, including recruiting and onboarding; Workday Learning, a blended learning solution that provides employees with online, self-paced training; and Workday Analytics, a business intelligence solution that provides real-time insights, visualizations and dashboards for business performance, HR and financial data. Workday’s customers include more than 5 million employees across 24,000 organizations in 43 countries. The company’s core HR solution has been deployed in over 1,200 organizations, including The Home Depot, VF Corp, Chevron, and Target. Workday has a market cap of $27.1 billion. The company has a P/E ratio of 11.4, a P/S ratio of 6.0, and a P/B ratio of 1.8. Workday has a 5-year average ROE of 24%, a 5-year average ROC of 33%, and a 5-year average gross margin of 69%.
Globus Medical Inc (NYSE: GMED)
Globus Medical manufactures medical devices and supplies for orthopedic, spinal, and general surgery procedures. The company’s products include spinal implants and instruments, orthopedic implants and instruments, sports medicine products, crutches, walkers, canes, lift chairs, and rehabilitation products. Globus Medical is also involved in the research, design, and development of new products and technologies in its engineering research and development department, ERD. Globus Medical’s products are delivered to its customers through distributors and independent sales representatives. The company’s products are used in hospitals, surgery centers, and other health care facilities. Globus Medical has a market cap of $2.5 billion. The company has a P/E ratio of 8.5, a P/S ratio of 1.3, and a P/B ratio of 1.8. Globus Medical has a 5-year average ROE of 20%, a 5-year average ROC of 25%, and a 5-year average gross margin of 70%.
Conclusion
Investing in the stock market can be a tricky proposition for some investors. There are many ways to invest in stocks, and there are many stocks to choose from. The trick to investing successfully is to find a company that will grow and is victorious over the long term. You can find the best stocks to invest in by looking for companies with a strong track record, a history of profitability, growing sales, and a strong product or service. Beyond that, you should also do your research and due diligence to ensure that the company you want to invest in is an excellent long-term investment. We hope you find these stocks as exciting and promising as we do. These are great stocks to invest in, and they can make you lots of money if you buy them now and hold on to them for the long term. If you’re ready to start investing, check out our guide to building a diversified portfolio.
